IL13 and asthma: Our results display that both T cells and ILCs seem to contribute to the production of IL-5 and IL-13 when OVA in alum induced asthma, suggesting both immune response pathways of Th2 cells and ILCs can be therapeutic targets for preventing or treating asthma.